Jul 26, 2024, 12:00 AM
Jul 26, 2024, 12:00 AM
Ozempic Boosts Denmark's Economy but Raises Concerns
- Novo Nordisk's Ozempic has significantly boosted Denmark's economy through high sales.
- Despite the economic benefits, concerns over the sustainability of this growth and potential risks have emerged.
- The stratospheric growth prompts a reevaluation of its long-term implications for the nation's economy.
Opinions
You've reached the end